Get notified of page updates
Cancer Risks, Screening and Prevention for People with Lynch Syndrome
September 29, 2021
Learn about the cancer risks associated with an inherited mutation in the MLH1, MSH2, MSH6, PMS2 or EPCAM and the risk-management options for people with an inherited mutation in one of these genes.Presented by Heather Hampel, CGC (The Ohio State University).
Who Should Attend?
People who have been diagnosed with Lynch syndrome, their relatives and caregivers, and people with a personal or family history of cancer who are interested in learning more about genetic testing for Lynch syndrome.